The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Antitumor activity of ASP8273 300 mg in subjects with EGFR mutation-positive non-small cell lung cancer: Interim results from an ongoing phase 1 study.

Helena Alexandra  Yu

Consulting or Advisory Role - AstraZeneca

Research Funding - Astellas Pharma; AstraZeneca; Clovis Oncology; Esanex; Incyte; Pfizer

Alexander I.  Spira

Honoraria - Novartis; Roche

Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; MedImmune; Roche

Expert Testimony - Novartis

Travel, Accommodations, Expenses - Roche

Leora  Horn

Honoraria - Biodesix

Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Merck; Puma Biotechnology; Xcovery

Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)

Jared  Weiss

Stock and Other Ownership Interests  - Pharmacyclics

Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; EMD Serono; Lilly; OncoPlex Diagnostics

Research Funding - Acceleron Pharma; Astellas Pharma; Celgene; GlaxoSmithKline; MedImmune; Pfizer

Howard Jack  West

Honoraria - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer

Consulting or Advisory Role - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer

Travel, Accommodations, Expenses - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Novartis

Giuseppe  Giaccone

Consulting or Advisory Role - Astex Pharmaceuticals; Boehringer Ingelheim; Celgene; Clovis Oncology; Inivata

Research Funding - AstraZeneca; Karyopharm Therapeutics

Tracey L.  Evans

Honoraria - Celgene; Genentech; Genentech (I); Lilly

Consulting or Advisory Role - Celgene; Genentech; Genentech (I); Lilly

Speakers' Bureau - Genentech (I)

Research Funding - Sanofi

Travel, Accommodations, Expenses - Celgene; Genentech; Genentech (I); Lilly; Sanofi

Ronan Joseph  Kelly

Consulting or Advisory Role - Clovis Oncology; Lilly; Novartis

Bhardwaj B.  Desai

Employment - Astellas Pharma

Travel, Accommodations, Expenses - Astellas Pharma

Andrew  Krivoshik

Employment - Astellas Pharma

Stock and Other Ownership Interests  - Abbott Laboratories; Abbott Laboratories (I); Abbvie; Abbvie (I); Johnson & Johnson; Johnson & Johnson (I); Merck; Merck (I)

Patents, Royalties, Other Intellectual Property - Abbott Laboratories; Abbvie

Travel, Accommodations, Expenses - Astellas Pharma

Tanya E.  Fleege

Employment - Astellas Pharma

Srinivasu  Poondru

Employment - Astellas Pharma

Travel, Accommodations, Expenses - Astellas Pharma

Fei  Jie

Employment - Astellas Pharma

Kouji  Aoyama

Employment - Astellas Pharma

Debbie Ann  Whitcomb

Employment - Astellas Pharma

Travel, Accommodations, Expenses - Astellas Pharma

Anne Therese  Keating

Employment - Astellas Pharma

Travel, Accommodations, Expenses - Astellas Pharma

Geoffrey R.  Oxnard

Honoraria - AstraZeneca; Chugai Pharma

Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Inivata; Sanofi; Sysmex

Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)